Učitavanje...
Non‐canonical cMet regulation by vimentin mediates Plk1 inhibitor–induced apoptosis
To address the need for improved systemic therapy for non–small‐cell lung cancer (NSCLC), we previously demonstrated that mesenchymal NSCLC was sensitive to polo‐like kinase (Plk1) inhibitors, but the mechanisms of resistance in epithelial NSCLC remain unknown. Here, we show that cMet was differenti...
Spremljeno u:
| Izdano u: | EMBO Mol Med |
|---|---|
| Glavni autori: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6505578/ https://ncbi.nlm.nih.gov/pubmed/31040125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201809960 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|